High-Dimensional Mediation Analysis for Generalized Linear Models Using Bayesian Variable Selection Guided by Mediator Correlation

📅 2026-02-12
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
This study addresses the challenges of high-dimensional mediation analysis, where mediators are numerous, highly interdependent, and associated with non-continuous outcomes—conditions under which conventional methods often neglect mediator correlations, leading to reduced statistical power. To overcome these limitations, the authors propose a Bayesian generalized linear framework that models mediators jointly via a multivariate distribution and incorporates a Markov random field prior to capture structural dependencies between the exposure and mediators. Additionally, an ordered subset Bernoulli prior is introduced to enforce sparsity in the mediator–outcome pathways, enabling simultaneous variable selection and pathway identification. Simulations demonstrate that the method achieves superior selection accuracy and power when mediators are correlated, maintains proper control of the family-wise error rate under the global null, and remains robust to model misspecification. Applied to metabolomics data, it successfully identifies key metabolites mediating the effect of Mediterranean diet on cardiometabolic outcomes.

Technology Category

Application Category

📝 Abstract
High-dimensional mediation analysis aims to identify mediating pathways and to estimate indirect effects linking an exposure to an outcome. In this paper, we propose a Bayesian framework to address key challenges in these analyses, including high dimensionality, complex dependence among omics mediators, and non-continuous outcomes. Furthermore, commonly used approaches assume independent mediators or ignore correlations in the selection stage, which can reduce power when mediators are highly correlated. Addressing these challenges leads to a non-Gaussian likelihood and specialized selection priors, which in turn require efficient and adaptive posterior computation. Our proposed framework selects active pathways under generalized linear models while accounting for mediator dependence. Specifically, the mediators are modeled using a multivariate distribution, exposure-mediator selection is guided by a Markov random field prior on inclusion indicators, and mediator-outcome activation is restricted to mediators supported in the exposure-mediator model through a sequential subsetting Bernoulli prior. Simulation studies show improved operating characteristics in correlated-mediator settings, with appropriate error control under the global null and stable performance under model misspecification. We illustrate the method using real-world metabolomics data to study metabolites that mediate the association between adherence to the Alternate Mediterranean Diet score and two cardiometabolic outcomes.
Problem

Research questions and friction points this paper is trying to address.

high-dimensional mediation analysis
mediator correlation
generalized linear models
non-continuous outcomes
omics mediators
Innovation

Methods, ideas, or system contributions that make the work stand out.

Bayesian variable selection
high-dimensional mediation analysis
mediator correlation
Markov random field prior
generalized linear models
Y
Youngho Bae
Department of Statistics, Sungkyunkwan University, Seoul, South Korea
Chanmin Kim
Chanmin Kim
Sungkyunkwan University / Boston University
Causal inferenceBayesian NonparametricsMediation AnalysisAir pollution epidemiology
F
Fenglei Wang
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, U.S.A.
Q
Qi Sun
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, U.S.A.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, U.S.A.; Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, MA, U.S.A.
K
Kyu Ha Lee
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, U.S.A.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, U.S.A.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, U.S.A.